The role of the oncogenic Rab35 in cancer invasion, metastasis, and immune evasion, especially in leukemia
Open Access
- 28 May 2018
- journal article
- other
- Published by Taylor & Francis in Small GTPases
- Vol. 11 (5) , 334-345
Abstract
The study of cancer has allowed researchers to describe some biological characteristics that tumor cells acquire during their development, known as the “hallmarks of cancer” but more research is needed to expand our knowledge about cancer biology and to generate new strategies of treatment. The role that RabGTPases might play in some hallmarks of cancer represents interesting areas of study since these proteins are frequently altered in cancer. However, their participation is not well known. Recently, Rab35was recognized as an oncogenic RabGTPase and and because of its association with different cellular functions, distinctly important in immune cells, a possible role of Rab35 in leukemia can be suggested. Nevertheless, the involvement of Rab35 in cancer remains poorly understood and its possible specific role in leukemia remains unknown. In this review, we analyze general aspects of the participation of RabGTPases in cancer, and especially, the plausible role of Rab35 in leukemia.Keywords
Funding Information
- Federal Funds Children's Hospital of Mexico (HIM 2014/003 SSA 1129)
- Federal Funds Children's Hospital of Mexico (HIM 2015/005 SSA 1182)
This publication has 147 references indexed in Scilit:
- Modulation of Rab GTPase function by a protein phosphocholine transferaseNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1Journal of Biological Chemistry, 2010
- Recycling of the Ca2+-activated K+ Channel, KCa2.3, Is Dependent upon RME-1, Rab35/EPI64C, and an N-terminal DomainJournal of Biological Chemistry, 2010
- The Connecdenn DENN Domain: A GEF for Rab35 Mediating Cargo-Specific Exit from Early EndosomesMolecular Cell, 2010
- Androgen-related expression of G-proteins in ovarian cancerBritish Journal of Cancer, 2009
- Major Histocompatibility Complex Class II-Peptide Complexes Internalize Using a Clathrin- and Dynamin-independent Endocytosis PathwayJournal of Biological Chemistry, 2008
- Regulation of endocytic recycling by C. elegans Rab35 and its regulator RME‐4, a coated‐pit proteinThe EMBO Journal, 2008
- The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersNature Medicine, 2004
- The Hallmarks of CancerCell, 2000